The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Recent Advances in the Management of Mucormycosis: From Bench to Bedside
Open accessAbstract
Recent therapeutic advances have the potential to improve outcomes of mucormycosis. Lipid formulations of amphotericin B (LFAB) have evolved as the cornerstone of primary therapy for mucormycosis. Posaconazole may be useful as salvage therapy, but it cannot be recommended as primary therapy for mucormycosis on the basis of available data. Preclinical and limited retrospective clinical data suggest that combination LFAB-echinocandin therapy may improve survival during mucormycosis. A definitive trial is needed to confirm these results. Combination therapy with LFAB and the iron chelator, deferasirox, also improved outcomes in animal models of mucormycosis. In contrast, combination polyene-posaconazole therapy was of no benefit in preclinical studies. Adjunctive therapy with recombinant cytokines, hyperbaric oxygen, and/or granulocyte transfusions can be considered for selected patients. Early initiation of therapy is critical to maximizing outcomes; recent developments in polymerase chain reaction technology are advancing early diagnostic strategies. Prospective, randomized clinical trials are needed to define optimal management strategies for mucormycosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Self-citationA higher-level phylogenetic classification of the Fungi
Hibbett, D. S., Binder, M., Bischoff, J. F., Blackwell, M., Cannon, P. F., Eriksson, O. E., Huhndorf, S., James, T., Kirk, P. M., Lücking, R., et al. (2007) · Mycological Research · doi:10.1016/j.mycres.2007.03.004 · Cited by 2,390
Ribes, J. A., Vanover-Sams, C. L., & Baker, D. J. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.236 · Cited by 1,711
Novel perspectives on mucormycosis: pathophysiology, presentation, and management
Spellberg, B., Edwards, J., & Ibrahim, A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.556-569.2005 · Cited by 1,537
Self-citationEpidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Self-citationChamilos, G., Lewis, R. E., & Kontoyiannis, D. P. (2008) · Clinical Infectious Diseases · doi:10.1086/590004 · Cited by 826
Self-citationWalsh, T. J., Raad, I., Patterson, T. F., Chandrasekar, P., Donowitz, G. R., Graybill, R., Greene, R. E., Hachem, R., Hadley, S., Herbrecht, R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 752
Self-citationCappellini, M. D. (2006) · Blood · doi:10.1182/blood-2005-08-3430 · Cited by 717
Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 674
Self-citationWalsh, T. J., Hiemenz, J. W., Seibel, N. L., Perfect, J. R., Horwith, G., Lee, L., Silber, J. L., DiNubile, M. J., Reboli, A., Bow, E., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516353 · Cited by 629
Self-citationPosaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases
van Burik, J.-A. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/500212 · Cited by 615
Self-citationPosaconazole as Salvage Therapy for Zygomycosis
Greenberg, R. N., Mullane, K., van Burik, J.-A. H., Raad, I., Abzug, M. J., Anstead, G., Herbrecht, R., Langston, A., Marr, K. A., Schiller, G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.126-133.2006 · Cited by 555
Wingard, J. R., White, M. H., Anaissie, E., Raffalli, J., Goodman, J., Arrieta, A., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 527
Zygomycosis in the 1990s in a Tertiary-Care Cancer Center
Kontoyiannis, D. P., Wessel, V. C., Bodey, G. P., & Rolston, K. V. I. (2000) · Clinical Infectious Diseases · doi:10.1086/313803 · Cited by 521
Self-citationCombination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral Mucormycosis
Reed, C., Bryant, R., Ibrahim, A. S., Edwards, Jr., Filler, S. G., Goldberg, R., & Spellberg, B. (2008) · Clinical Infectious Diseases · doi:10.1086/589857 · Cited by 494
Self-citationAntifungal therapeutic drug monitoring: established and emerging indications
Andes, D., Pascual, A., & Marchetti, O. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00705-08 · Cited by 490
Pulmonary mucormycosis: Results of medical and surgical therapy
Tedder, M., Spratt, J. A., Anstadt, M. P., Hegde, S. S., Tedder, S. D., & Lowe, J. E. (1994) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)90243-7 · Cited by 452
Marty, F. M., Cosimi, L. A., & Baden, L. R. (2004) · New England Journal of Medicine · doi:10.1056/nejm200402263500923 · Cited by 426
Pfaller, M. A., Messer, S. A., Hollis, R. J., & Jones, R. N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1032-1037.2002 · Cited by 404
Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole
Imhof, A., Balajee, S. A., Fredricks, D. N., Englund, J. A., & Marr, K. A. (2004) · Clinical Infectious Diseases · doi:10.1086/423274 · Cited by 402
Walsh, T. J., Goodman, J. L., Pappas, P., Bekersky, I., Buell, D. N., Roden, M., Barrett, J., & Anaissie, E. J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3487-3496.2001 · Cited by 401
Self-citationGroll, A. H., Giri, N., Petraitis, V., Petraitiene, R., Candelario, M., Bacher, J. S., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373
Self-citationPredictors of Pulmonary Zygomycosis versus Invasive Pulmonary Aspergillosis in Patients with Cancer
Chamilos, G., Marom, E. M., Lewis, R. E., Lionakis, M. S., & Kontoyiannis, D. P. (2005) · Clinical Infectious Diseases · doi:10.1086/430710 · Cited by 369
Self-citationSun, Q. N., Fothergill, A. W., McCarthy, D. I., Rinaldi, M. G., & Graybill, J. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1581-1582.2002 · Cited by 365
Boelaert, J. R., de Locht, M., Van Cutsem, J., Kerrels, V, Cantinieaux, B., Verdonck, A., Van Landuyt, H. W., & Schneider, Y. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116419 · Cited by 340
In vitro susceptibilities of zygomycetes to conventional and new antifungals
Dannaoui, E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg020 · Cited by 314
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308
Self-citationAlmyroudis, N. G., Sutton, D. A., Fothergill, A. W., Rinaldi, M. G., & Kusne, S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00452-07 · Cited by 285
Ullmann, A. J., Cornely, O. A., Burchardt, A., Hachem, R., Kontoyiannis, D. P., Töpelt, K., Courtney, R., Wexler, D., Krishna, G., Martinho, M., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.658-666.2006 · Cited by 273
Self-citationPiga, A. G., Galanello, R., Forni, G. L., Cappellini, M. D., Origa, R., Zappu, A., Donato, G., Bordone, E., Lavagetto, A., Zanaboni, L., et al. (2006) · PubMed · Cited by 264
Rhinocerebral Mucormycosis: Evolution of the Disease and Treatment Options
Peterson, K. L., Wang, M., Canalis, R. F., & Abemayor, E. (1997) · The Laryngoscope · doi:10.1097/00005537-199707000-00004 · Cited by 243
Seibel, N. L., Schwartz, C., Arrieta, A., Flynn, P., Shad, A., Albano, E., Keirns, J., Lau, W. M., Facklam, D. P., Buell, D. N., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3317-3324.2005 · Cited by 243
Self-citationPharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents
Walsh, T. J., Adamson, P. C., Seibel, N. L., Flynn, P. M., Neely, M. N., Schwartz, C., Shad, A., Kaplan, S. L., Roden, M. M., Stone, J. A., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4536-4545.2005 · Cited by 239
Self-citationTrifilio, S. M., Bennett, C. L., Yarnold, P. R., McKoy, J. M., Parada, J., Mehta, J., Chamilos, G., Palella, F., Kennedy, L., Mullane, K., et al. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705614 · Cited by 230
Self-citationImproved Outcome of Zygomycosis in Patients with Hematological Diseases?
Gleissner, B., Schilling, A., Anagnostopolous, I., Siehl, I., & Thiel, E. (2004) · Leukemia & Lymphoma · doi:10.1080/10428190310001653691 · Cited by 227
Reversed Halo Sign in Invasive Pulmonary Fungal Infections
Wahba, H., Truong, M. T., Lei, X., Kontoyiannis, D. P., & Marom, E. M. (2008) · Clinical Infectious Diseases · doi:10.1086/587991 · Cited by 214
Self-citationBenjamin, D. K., Driscoll, T., Seibel, N. L., Gonzalez, C. E., Roden, M. M., Kilaru, R., Clark, K., Dowell, J. A., Schranz, J., & Walsh, T. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.632-638.2006 · Cited by 210
Self-citationIbrahim, A. S., Bowman, J. C., Avanessian, V., Brown, K., Spellberg, B., Edwards, J. E., & Douglas, C. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.721-727.2005 · Cited by 207
Self-citationNithyanandam, S., Jacob, M. S., Battu, R., Thomas, R. K., Correa, M. A. R., & D’Souza, O. (2003) · PubMed · Cited by 197
Krishna, G., Martinho, M., Chandrasekar, P., Ullmann, A. J., & Patino, H. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.12.1627 · Cited by 195
Lamaris, G. A., Lewis, R. E., Chamilos, G., May, G. S., Safdar, A., Walsh, T. J., Raad, I. I., & Kontoyiannis, D. P. (2008) · The Journal of Infectious Diseases · doi:10.1086/589305 · Cited by 187
Self-citationSpellberg, B., Fu, Y., Edwards, J. E., & Ibrahim, A. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.830-832.2005 · Cited by 186
Self-citationIn Vivo Activity of Posaconazole against Mucor spp. in an Immunosuppressed-Mouse Model
Sun, Q. N., Najvar, L. K., Bocanegra, R., Loebenberg, D., & Graybill, J. R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2310-2312.2002 · Cited by 184
Combination Echinocandin-Polyene Treatment of Murine Mucormycosis
Ibrahim, A. S., Gebremariam, T., Fu, Y., Edwards, J. E., & Spellberg, B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01458-07 · Cited by 180
Self-citationZygomycosis: Reemergence of an Old Pathogen
Kauffman, C. A. (2004) · Clinical Infectious Diseases · doi:10.1086/422729 · Cited by 178
Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis
Andes, D., Marchillo, K., Conklin, R., Krishna, G., Ezzet, F., Cacciapuoti, A., & Loebenberg, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.137-142.2004 · Cited by 177
Gil‐Lamaignere, C., Simitsopoulou, M., Roilides, E., Maloukou, A., Winn, R. M., & Walsh, T. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/428503 · Cited by 169
Self-citationBoelaert, J. R., Van Cutsem, J., de Locht, M., Schneider, Y.-J., & Crichton, R. R. (1994) · Kidney International · doi:10.1038/ki.1994.89 · Cited by 168
Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
Dannaoui, E., Meis, J. F. G. M., Loebenberg, D., & Verweij, P. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3647-3650.2003 · Cited by 159
Deferiprone iron chelation as a novel therapy for experimental mucormycosis
Ibrahim, A. S., Edwards, J. E., Fu, Y., & Spellberg, B. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl350 · Cited by 156
Self-citationPosaconazole Plasma Concentrations in Juvenile Patients with Invasive Fungal Infection
Krishna, G., Sansone‐Parsons, A., Martinho, M., Kantesaria, B. S., & Pedicone, L. D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00454-06 · Cited by 155
Lass‐Flörl, C., Mayr, A., Perkhofer, S., Hinterberger, G., Hausdorfer, J., Speth, C., & Fille, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00662-08 · Cited by 154
van Burik, J. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · Cited by 140
Self-citationMucormycosis: Ten-Year Experience at a Tertiary-Care Center in Greece
Petrikkos, G. L., Skiada, A., Sambatakou, H., Toskas, A., Vaiopoulos, G., Giannopoulou, M., & Katsilambros, N. L. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1035-y · Cited by 137
Deferasirox, an Iron-Chelating Agent, as Salvage Therapy for Rhinocerebral Mucormycosis
Reed, C., Ibrahim, A. S., Edwards, J. E., Walot, I., & Spellberg, B. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01065-06 · Cited by 136
Self-citationGonzalez, C. E., Couriel, D. R., & Walsh, T. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.192 · Cited by 134
Self-citationKasai, M., Harrington, S. M., Francesconi, A., Petraitis, V., Petraitienė, R., Beveridge, M. G., Knudsen, T. A., Milanovich, J., Cotton, M. P., Hughes, J. E., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00917-08 · Cited by 130
Self-citationde Locht, M., Boelaert, J. R., & Schneider, Y. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90314-x · Cited by 124
Abzug, M. J., & Walsh, T. J. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000134314.65398.bf · Cited by 124
Self-citationVigouroux, S., Morin, O., Moreau, P., Mechinaud, F. M., Morineau, N., Mahé, B., Chevallier, P., Guillaume, T., Dubruille, V., Harousseau, J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427752 · Cited by 120
Clinical application of deferasirox: Practical patient management
Vichinsky, E. P. (2007) · American Journal of Hematology · doi:10.1002/ajh.21119 · Cited by 117
Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis
Ibrahim, A. S., Gebremariam, T., Schwartz, J. A., Edwards, J. E., & Spellberg, B. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01124-08 · Cited by 104
Self-citationPfaller, M. A., Messer, S. A., Mills, K., & Bolmström, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3359-3361.2000 · Cited by 99
Ibrahim, A. S., Avanesian, V., Spellberg, B. J., & Edwards, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3343-3344.2003 · Cited by 99
Self-citationRodríguez, M. M., Serena, C., Mariné, M., Pastor, F. J., & Guarro, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00628-08 · Cited by 97
Iron-chelating therapy with the new oral agent ICL670 (Exjade®)
Cappellini, M. D. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.002 · Cited by 96
Successful Medical Management of Isolated Renal Zygomycosis: Case Report and Review
Weng, D. E., Wilson, W. H., Little, R. F., & Walsh, T. J. (1998) · Clinical Infectious Diseases · doi:10.1086/514562 · Cited by 74
Self-citationNick, H., Wong, A. M.-L., Acklin, P., Faller, B., Jin, Y., Lattmann, R., Sergejew, T., Hauffe, S., Thomas, H., & Schnebli, H. P. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0593-8_10 · Cited by 72
Arıkan, S., Sancak, B., Alp, Ş., Hasçelik, G., & McNicholas, P. M. (2008) · Medical Mycology · doi:10.1080/13693780801975576 · Cited by 70
Comparison of Lipid Amphotericin B Preparations in Treating Murine Zygomycosis
Ibrahim, A. S., Gebremariam, T., Husseiny, M. I., Stevens, D. A., Fu, Y., Edwards, J. E., & Spellberg, B. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01488-07 · Cited by 64
Self-citationGrigull, L., Beilken, A., Schmid, H., Kirschner, P., Sykora, K.-W., Linderkamp, C., Donnerstag, F., Goudeva, L., Heuft, H.-G., & Welte, K. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-005-0910-8 · Cited by 63
Rhinocerebral mucormycosis in Taiwan.
Khor, B.-S., Lee, M., Leu, H., & Liu, J.-W. (2003) · PubMed · Cited by 60
Increased Culture Recovery of Zygomycetes Under Physiologic Temperature Conditions
Kontoyiannis, D. P., Chamilos, G., Hassan, S. A., Lewis, R. E., Albert, N. D., & Tarrand, J. J. (2007) · American Journal of Clinical Pathology · doi:10.1309/7ku5xwurym0151yn · Cited by 53
Self-citationFrancesconi, A., Kasai, M., Harrington, S. M., Beveridge, M. G., Petraitienė, R., Petraitis, V., Schaufele, R. L., & Walsh, T. J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02246-07 · Cited by 51
Self-citationPfaller, M. A., Messer, S. A., Boyken, L. B., Hollis, R. J., & Diekema, D. J. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00544-8 · Cited by 48
Miyazawa, K., Ohyashiki, K., Urabe, A., Hata, T., Nakao, S., Ozawa, K., Ishikawa, T., Kato, J., Tatsumi, Y., Mori, H., et al. (2008) · International Journal of Hematology · doi:10.1007/s12185-008-0115-2 · Cited by 40
Risikofaktoren für invasive Zygomykosen bei Patienten mit hämatologischen Neoplasien
Rickerts, V., Böhme, A., & Just‐Nübling, G. (2002) · Mycoses · doi:10.1111/j.1439-0507.2002.tb04542.x · Cited by 36
Soummer, A., Mathonnet, A., Scatton, O., Massault, P. P., Paugam, A., Lemiale, V., Mira, J. P., Dannaoui, É., Cariou, A., & Lortholary, O. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01611-07 · Cited by 36
Cytokines as therapy for opportunistic fungal infections
Kullberg, B. J., & Anaissie, E. J. (1998) · Research in Immunology · doi:10.1016/s0923-2494(98)80771-2 · Cited by 35
Simitsopoulou, M., Roilides, E., Maloukou, A., Gil‐Lamaignere, C., & Walsh, T. J. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01457.x · Cited by 33
Self-citationManagement of Bronchovascular Mucormycosis in a Diabetic: A Surgical Success
Reid, V. J., Solnik, D. L., Daskalakis, T., & Sheka, K. P. (2004) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)01406-1 · Cited by 32
Editorial Commentary:What is the Role of Combination Therapy in Management of Zygomycosis?
Walsh, T. J., & Kontoyiannis, D. P. (2008) · Clinical Infectious Diseases · doi:10.1086/589858 · Cited by 32
Self-citationTreatment of Experimental Zygomycosis in Guinea Pigs with Azoles and with Amphotericin B
Cutsem, J. V., Gerven, F. V., Fransen, J., & Janssen, P. H. (2009) · Chemotherapy · doi:10.1159/000238681 · Cited by 31
Asai, K., Suzuki, K. Z., Takahashi, T., Ito, Y., Kazui, T., & Kita, Y. (2003) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-003-0055-y · Cited by 28
Absolute Oral Bioavailability and Disposition of Deferasirox in Healthy Human Subjects
Séchaud, R., ROBEVA, A. S., Belleli, R., et al. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008320316 · Cited by 26
Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?
Ide, L. E. Y., Buysschaert, I., Demuynck, H., Man, R. D., Verlinde, A., Laere, E. D., & Surmont, I. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00945.x · Cited by 24
Meningitis owing to an unusual aetiological agent in an adult: Salmonella typhi
Gonen, I., & Akcam, F. Z. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021081 · Cited by 23
Pavie, J., Lafaurie, M., Lacroix, C., Zagdanski, A. M., Debrosse, D., Socié, G., Derouin, F., Gluckman, É., & Molina, J. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021081a · Cited by 21
Cited by
Skiada, A., Pagano, L., Groll, A., Zimmerli, S., Dupont, B., Lagrou, K., Lass-Florl, C., Bouza, E., Klimko, N., Gaustad, P., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03456.x · Cited by 748
GRP78: A cell's response to stress
Ibrahim, I. M., Abdelmalek, D. H., & Elfiky, A. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.022 · Cited by 647
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species
Gomes, M. Z. R., Lewis, R. E., & Kontoyiannis, D. P. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-10 · Cited by 443
Self-citationPost coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum
Sharma, S., Grover, M., Bhargava, S., Samdani, S., & Kataria, T. (2021) · The Journal of Laryngology & Otology · doi:10.1017/s0022215121000992 · Cited by 398
Kontoyiannis, D. P., & Lewis, R. E. (2011) · Blood · doi:10.1182/blood-2011-03-316430 · Cited by 376
Self-citation
Metadata
- Authors
- Spellberg, B., Walsh, T. J., Kontoyiannis, D. P., Edwards, Jr., & Ibrahim, A. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06-15
- Volume
- 48
- Issue
- 12
- Pages
- 1743-1751
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2146851458
- Cited by
- 548
- References
- 89
- FWCI
- 27.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.